Key Players in China's CDMO Pharma-Bio Market Push Forward
Key Players in China's CDMO Pharma-Bio Market Push Forward
BEIJING--June 11, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Key players in the Chinese contract development and manufacturing organization (CDMO) market such as Wuxi AppTec & Wuxi Biologics, Asymchem Laboratories (Tianjin) Co., Ltd., Porton Pharma Solutions Ltd., Apeloa Pharmaceutical Co., Ltd and Zhejiang Jiuzhou Pharmaceutical Co. Ltd, among others, have employed various strategies to expand their product and application offerings and global footprint, and augment their market share.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
